Amundi Asset Management US’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$97K Hold
1,100
﹤0.01% 1489
2020
Q4
$105K Sell
1,100
-50,225
-98% -$5.18M ﹤0.01% 1432
2020
Q3
$5.83M Buy
51,325
+7,837
+18% +$823K 0.01% 857
2020
Q2
$4.3M Buy
43,488
+8,549
+24% +$682K 0.01% 911
2020
Q1
$2.25M Sell
34,939
-1,004
-3% -$70.3K ﹤0.01% 928
2019
Q4
$2.14M Buy
+35,943
New +$2.22M ﹤0.01% 1108

Other funds holding TNDM

Amundi Asset Management US's TNDM Position: Q1 2021 in Review

Amundi Asset Management US held its Tandem Diabetes Care (TNDM) position steady in Q1 2021 at 1,100 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Amundi Asset Management US first reported a position in TNDM in Q4 2019 and has held it in 6 quarters since. The position peaked at $5.83M in Q3 2020. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Amundi Asset Management US held 1,100 shares of Tandem Diabetes Care worth $97K as of Q1 2021.
  • Amundi Asset Management US left its Tandem Diabetes Care share count unchanged in Q1 2021.
  • Tandem Diabetes Care made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1489 holding.
  • Amundi Asset Management US first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 6 quarters since.
  • Amundi Asset Management US's Tandem Diabetes Care position peaked at $5.83M in Q3 2020.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.